Quantification of Global Ocular Motility Impairment in Graves' Orbitopathy by Measuring Eye Muscle Ductions-Reference-Cited by-同舟云学术

Quantification of Global Ocular Motility Impairment in Graves' Orbitopathy by Measuring Eye Muscle Ductions

Published:2021-02-01 Issue:2 Volume:31 Page:280-287
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Campi Irene¹²,Currò Nicola³,Vannucchi Guia¹,Covelli Danila⁴,Simonetta Simona³,Fugazzola Laura¹²,Dazzi Davide⁵,Pignataro Lorenzo⁶⁷,Guastella Claudio⁶⁷,Lazzaroni Elisa⁴,Pirola Giacinta³,Salvi Mario⁴

Affiliation:

1. Division of Endocrine and Metabolic Diseases and Laboratory of Endocrine and Metabolic Research, IRCCS Istituto Auxologico Italiano, Milan, Italy.

2. Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.

3. Ophthalmology Unit, Department of Surgery, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Milan, Italy.

4. Graves' Orbitopathy Center, Endocrinology, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Milan, Italy.

5. Division of Internal Medicine, Ospedale Vaio, Fidenza, Italy.

6. ENT Unit, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Milan, Italy.

7. Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2020.0165

Reference24 articles.

1. Psychosocial morbidity of Graves' orbitopathy

2. The Effects of Strabismus on Quality of Life in Adults

3. Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial

4. Efficacy and Safety of Three Different Cumulative Doses of Intravenous Methylprednisolone for Moderate to Severe and Active Graves' Orbitopathy

5. Efficacy of B-Cell Targeted Therapy With Rituximab in Patients With Active Moderate to Severe Graves' Orbitopathy: A Randomized Controlled Study

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CT-based artificial intelligence prediction model for ocular motility score of thyroid eye disease;Endocrine;2024-07-24

2. A protocol to quantify cross-sectional and longitudinal differences in duction patterns;Frontiers in Neuroscience;2024-06-11

3. The changing landscape of thyroid eye disease: current clinical advances and future outlook;Eye;2024-02-19

4. Quality of Life Studies in Thyroid-Associated Orbitopathy;Oculoplastic, Lacrimal and Orbital Surgery;2024

5. Aktuelle Therapieansätze der endokrinen Orbitopathie – sind die zielgerichteten Therapien die Zukunft?;Klinische Monatsblätter für Augenheilkunde;2023-10-05